FAMILIAL PEDIGREE CHARACTERISTICS IN CASES OF LYNCH SYNDROME
Main Article Content
Abstract
Lynch syndrome is a hereditary disorder that increases the risk of various cancers, particularly colorectal cancer, endometrial cancer, and several other types. It is primarily caused by mutations in DNA mismatch repair (MMR) genes, including MLH1, MSH2, MSH6, PMS2, and EPCAM. Identifying cases of Lynch syndrome is crucial for cancer screening, genetic counseling, and prevention in both patients and their relatives. This study describes eight cases of individuals diagnosed with Lynch syndrome through genetic testing that detected mutations in MMR genes. Among the eight cases, the mutated genes identified were: MLH1 in 4 cases, MSH2 in 1 case, PMS2 in 2 cases, and EPCAM in 1 case. All eight patients had at least one first- or second-degree relative who had cancer or died prematurely from the disease. The pedigree characteristics showed a recurrence of cancer across generations within families or multiple family members being diagnosed with cancer. Lynch syndrome is clearly reflected in family cancer history and can be confirmed through MMR gene testing. Early detection of individuals carrying MMR mutations enables timely intervention, improves treatment outcomes, and enhances cancer screening for both patients and their relatives. It is recommended that genetic testing be extended to family members of affected individuals to help prevent and detect cancer at an early stage
Article Details
Keywords
Cancer Genetics, MMR gene, Lynch Syndrome, Pedigree
References
2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric. Version 3.2024 — October 31, 2024; Accessed: February 26, 2025.
3. Bhattacharya P, Leslie SW, McHugh TW. Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) [Updated 2024 Jun 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan).
4. Clinicopathological features of Lynch syndrome pedigrees with MSH2 c.351G>A gene variant. Mol Genet Genomic Med. 2025;13(1). Published by Wiley.
5. Jakob D, Orth V, Gödde D, Zirngibl H, Ambe PC. Family history as a major prerequisite for microsatellite instability screening in colorectal cancer is a poor selection tool. Transl Gastroenterol Hepatol. 2024;9:17.
6. Joost P, Therkildsen C, Dominguez-Valentin M, Jönsson M, Nilbert M. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations. Urology. 2015;86(6):1212-1217. doi:10.1016/j.urology.2015.08.018